Novartis breaks ground on Texas radioligand therapy manufacturing site

Go back to Novartis breaks ground on Texas radioligand therapy manufacturing site

Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities

May 7, 2026 9:00 AM EDT

US Under Secretary of Commerce Jeffrey Kessler, Texas State Senator Brent Hagenbuch, Novartis leadership mark expansion of companys coast-to-coast RLT manufacturing network the largest in the US

Expanded infrastructure brings highly personalized cancer therapies closer to patients across the southern US

Denton groundbreaking is latest milestone in Novartis $23 billion investment in US research and manufacturing

East Hanover, May 7, 2026 Novartis, a leading global innovative medicines company, today broke ground on its new 46,000 sq. ft radioligand therapy (RLT) manufacturing site in Denton, Texas,... More